{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:40:18Z","timestamp":1773294018801,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ADHD Atten Def Hyp Disord"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12402-016-0198-1","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T11:24:49Z","timestamp":1462274689000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy"],"prefix":"10.1007","volume":"8","author":[{"given":"Minji","family":"Sohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Talbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela C.","family":"Moga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Blumenschein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"issue":"2","key":"198_CR1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","volume":"14","author":"MG Aman","year":"2004","unstructured":"Aman MG, Binder C, Turgay A (2004) Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol 14(2):243\u2013254","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"198_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1542\/peds.2011-0855","volume":"128","author":"SE Andrade","year":"2011","unstructured":"Andrade SE, Lo JC, Roblin D et al (2011) Antipsychotic medication use among children and risk of diabetes mellitus. Pediatrics 128(6):1135\u20131141","journal-title":"Pediatrics"},{"issue":"5","key":"198_CR3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/chi.0b013e3180323354","volume":"46","author":"JL Armenteros","year":"2007","unstructured":"Armenteros JL, Lewis JE, Davalos M (2007) Risperidone augmentation for treatment-resistant aggression in attention-deficit\/hyperactivity disorder: a placebo-controlled pilot study. J Am Acad Child Adolesc Psychiatry 46(5):558\u2013565","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"198_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/chi.0b013e31815d88b2","volume":"47","author":"ME Bangs","year":"2008","unstructured":"Bangs ME, Tauscher-Wisniewski S, Polzer J et al (2008) Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry 47(2):209\u2013218","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"198_CR5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DBP.0b013e3180cabc28","volume":"28","author":"WJ Barbaresi","year":"2007","unstructured":"Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ (2007) Modifiers of long-term school outcomes for children with attention-deficit\/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr 28(4):274\u2013287","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"198_CR6","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","volume":"121","author":"J Biederman","year":"2008","unstructured":"Biederman J, Melmed RD, Patel A et al (2008) A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. Pediatrics 121(1):e73\u2013e84","journal-title":"Pediatrics"},{"issue":"10","key":"198_CR7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","volume":"70","author":"WV Bobo","year":"2013","unstructured":"Bobo WV, Cooper WO, Stein CM et al (2013) Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry 70(10):1067\u20131075","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"198_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-4356(02)00588-7","volume":"56","author":"JB Buse","year":"2003","unstructured":"Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L (2003) A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol 56(2):164\u2013170","journal-title":"J Clin Epidemiol"},{"key":"198_CR201","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","volume":"19","author":"S Chinn","year":"2000","unstructured":"Chinn S (2000) A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med 19:3127\u20133131","journal-title":"Stat Med"},{"key":"198_CR9","unstructured":"Consumer reports best buy drugs (2012) Evaluating prescription drug used to treat: attention deficit hyperactivity disorder (ADHD). http:\/\/www.CRBestBuyDrugs.org"},{"issue":"2","key":"198_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","volume":"6","author":"WO Cooper","year":"2006","unstructured":"Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA (2006) Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr 6(2):79\u201383","journal-title":"Ambul Pediatr"},{"issue":"16","key":"198_CR11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK (2009) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA J Am Med Assoc 302(16):1765\u20131773","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"198_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/cap.2011.0024","volume":"21","author":"CU Correll","year":"2011","unstructured":"Correll CU, Harris J, Figen V, Kane JM, Manu P (2011) Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study. J Child Adolesc Psychopharmacol 21(4):365\u2013368","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"198_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/chi.0b013e31815d9ae4","volume":"47","author":"WB Daviss","year":"2008","unstructured":"Daviss WB, Patel NC, Robb AS et al (2008) Clonidine for attention-deficit\/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry 47(2):189\u2013198","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"198_CR14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/cap.2006.0091","volume":"17","author":"SS Gau","year":"2007","unstructured":"Gau SS, Huang YS, Soong WT et al (2007) A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 17(4):447\u2013460","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"198_CR15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5694\/j.1326-5377.2001.tb143717.x","volume":"175","author":"RD Goldney","year":"2001","unstructured":"Goldney RD, Fisher LJ, Wilson DH, Cheok F (2001) Suicidal ideation and health-related quality of life in the community. Med J Aust 175(10):546\u2013549","journal-title":"Med J Aust"},{"issue":"1","key":"198_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/YIC.0b013e3283400d58","volume":"26","author":"DW Hough","year":"2011","unstructured":"Hough DW, Natarajan J, Vandebosch A, Rossenu S, Kramer M, Eerdekens M (2011) Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol 26(1):25\u201334","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"198_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaac.2010.11.005","volume":"50","author":"R Jain","year":"2011","unstructured":"Jain R, Segal S, Kollins SH, Khayrallah M (2011) Clonidine extended-release tablets for pediatric patients with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50(2):171\u2013179","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"198_CR18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1176\/appi.ajp.162.9.1628","volume":"162","author":"PS Jensen","year":"2005","unstructured":"Jensen PS, Garcia JA, Glied S et al (2005) Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry 162(9):1628\u20131636","journal-title":"Am J Psychiatry"},{"issue":"3","key":"198_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/cap.1998.8.151","volume":"8","author":"DL Kelly","year":"1998","unstructured":"Kelly DL, Conley RR, Love RC, Horn DS, Ushchak CM (1998) Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months. J Child Adolesc Psychopharmacol 8(3):151\u2013159","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"198_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","volume":"114","author":"DK Kelsey","year":"2004","unstructured":"Kelsey DK, Sumner CR, Casat CD et al (2004) Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 114(1):e1\u2013e8","journal-title":"Pediatrics"},{"issue":"20","key":"198_CR21","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.286.20.2542","volume":"286","author":"E Koller","year":"2001","unstructured":"Koller E, Malozowski S, Doraiswamy PM (2001) Atypical antipsychotic drugs and hyperglycemia in adolescents. JAMA J Am Med Assoc 286(20):2547\u20132548","journal-title":"JAMA J Am Med Assoc"},{"issue":"2","key":"198_CR22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1542\/peds.113.2.421","volume":"113","author":"EA Koller","year":"2004","unstructured":"Koller EA, Cross JT, Schneider B (2004) Risperidone-associated diabetes mellitus in children. Pediatrics 113(2):421\u2013422","journal-title":"Pediatrics"},{"issue":"4","key":"198_CR23","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1542\/peds.2010-0825","volume":"127","author":"CJ Kratochvil","year":"2011","unstructured":"Kratochvil CJ, Vaughan BS, Stoner JA et al (2011) A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics 127(4):e862\u2013e868","journal-title":"Pediatrics"},{"issue":"1","key":"198_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00787-009-0042-7","volume":"19","author":"F Martenyi","year":"2010","unstructured":"Martenyi F, Zavadenko NN, Jarkova NB et al (2010) Atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. Eur Child Adolesc Psychiatry 19(1):57\u201366","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"198_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/cap.2000.10.259","volume":"10","author":"A Martin","year":"2000","unstructured":"Martin A, Landau J, Leebens P et al (2000) Risperidone-associated weight gain in children and adolescents: a retrospective chart review. J Child Adolesc Psychopharmacol 10(4):259\u2013268","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"198_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0272989X9701700203","volume":"17","author":"G Naglie","year":"1997","unstructured":"Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS (1997) Primer on medical decision analysis: part 3\u2013estimating probabilities and utilities. Med Decis Making 17(2):136\u2013141","journal-title":"Med Decis Making"},{"issue":"4 Suppl","key":"198_CR27","first-page":"S117","volume":"10","author":"M Olfson","year":"2004","unstructured":"Olfson M (2004) New options in the pharmacological management of attention-deficit\/hyperactivity disorder. Am J Managed Care 10(4 Suppl):S117\u2013S124","journal-title":"Am J Managed Care"},{"issue":"2","key":"198_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1176\/ps.2010.61.2.123","volume":"61","author":"P Pathak","year":"2010","unstructured":"Pathak P, West D, Martin BC, Helm ME, Henderson C (2010) Evidence-based use of second-generation antipsychotics in a state medicaid pediatric population, 2001\u20132005. Psychiatr Serv 61(2):123\u2013129","journal-title":"Psychiatr Serv"},{"issue":"8","key":"198_CR29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.jhh.1001427","volume":"16","author":"A Remkova","year":"2002","unstructured":"Remkova A, Kratochvil\u2019ova H (2002) Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension. J Hum Hypertens 16(8):549\u2013555","journal-title":"J Hum Hypertens"},{"issue":"3","key":"198_CR30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/cap.2010.0135","volume":"22","author":"FR Sallee","year":"2012","unstructured":"Sallee FR, Kollins SH, Wigal TL (2012) Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 22(3):206\u2013214","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"198_CR31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.18553\/jmcp.2012.18.9.676","volume":"18","author":"V Sikirica","year":"2012","unstructured":"Sikirica V, Pliszka SR, Betts KA et al (2012) Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. J Managed Care Pharm JMCP 18(9):676\u2013689","journal-title":"J Managed Care Pharm JMCP"},{"issue":"6","key":"198_CR32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pds.3768","volume":"24","author":"M Sohn","year":"2015","unstructured":"Sohn M, Talbert J, Blumenschein K, Moga DC (2015) Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents. Pharmacoepidemiol Drug Saf 24(6):583\u2013591","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"198_CR33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2654","volume":"128","author":"Subcommittee on Attention-Deficit\/Hyperactivity D, Steering Committee on Quality I, Management","year":"2011","unstructured":"Subcommittee on Attention-Deficit\/Hyperactivity D, Steering Committee on Quality I, Management et al (2011) ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 128(5):1007\u20131022","journal-title":"Pediatrics"},{"issue":"4","key":"198_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/cap.2008.0154","volume":"19","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Takita Y, Yamazaki K et al (2009) A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(4):341\u2013350","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"198_CR200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/01632780122034939","volume":"24","author":"L Tickle-Degnen","year":"2001","unstructured":"Tickle-Degnen L (2001) From the general to the specific. Using meta-analytic reports in clinical decision making. Eval Health Prof 24:308\u2013326","journal-title":"Eval Health Prof"},{"issue":"5","key":"198_CR35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","volume":"70","author":"S Tramontina","year":"2009","unstructured":"Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA (2009) Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry 70(5):756\u2013764","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"198_CR36","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1542\/peds.2006-3778","volume":"121","author":"K Uzark","year":"2008","unstructured":"Uzark K, Jones K, Slusher J, Limbers CA, Burwinkle TM, Varni JW (2008) Quality of life in children with heart disease as perceived by children and parents. Pediatrics 121(5):e1060\u2013e1067","journal-title":"Pediatrics"},{"key":"198_CR37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7525-4-26","volume":"4","author":"JW Varni","year":"2006","unstructured":"Varni JW, Burwinkle TM (2006) The PedsQL as a patient-reported outcome in children and adolescents with attention-deficit\/hyperactivity disorder: a population-based study. Health Qual Life Outcomes 4:26","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"198_CR38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.26.3.631","volume":"26","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL (2003) The PedsQL in type 1 and type 2 diabetes: reliability and validity of the pediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 26(3):631\u2013637","journal-title":"Diabetes Care"},{"issue":"5","key":"198_CR39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/cap.2009.0050","volume":"19","author":"M Weiss","year":"2009","unstructured":"Weiss M, Panagiotopoulos C, Giles L et al (2009) A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit\/hyperactivity disorder clinic. J Child Adolesc Psychopharmacol 19(5):575\u2013582","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"198_CR40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00002018-200326100-00006","volume":"26","author":"JF Wernicke","year":"2003","unstructured":"Wernicke JF, Faries D, Girod D et al (2003) Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 26(10):729\u2013740","journal-title":"Drug Saf"},{"issue":"1","key":"198_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.293.1.70","volume":"293","author":"J Williams","year":"2005","unstructured":"Williams J, Wake M, Hesketh K, Maher E, Waters E (2005) Health-related quality of life of overweight and obese children. JAMA J Am Med Assoc 293(1):70\u201376","journal-title":"JAMA J Am Med Assoc"}],"container-title":["ADHD Attention Deficit and Hyperactivity Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-016-0198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12402-016-0198-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-016-0198-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T10:42:59Z","timestamp":1600512179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12402-016-0198-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s12402-016-0198-1","relation":{},"ISSN":["1866-6116","1866-6647"],"issn-type":[{"value":"1866-6116","type":"print"},{"value":"1866-6647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]}}}